Teon Therapeutics gathers $30m Series A

Teon Therapeutics, a biopharmaceutical company, has closed $30 million in Series A financing.

Teon Therapeutics, a biopharmaceutical company, has closed $30 million in Series A financing. Oceanpine Capital led the round with participation other investors that include Oriza Ventures, Lifespan Investments, Northern Light Venture Capital, Kaitai Capital and Oriental Fortune Capital.

Source: Press Release